SOX9 expression and its methylation status in gastric cancer

Virchows Archiv

Volumn 460, Issue 3, 2012, Pages 271-279

  Sun, Minhua ^a   Uozaki, Hiroshi ^a   Hino, Rumi ^a   Kunita, Akiko ^a   Shinozaki, Aya ^a   Ushiku, Tetsuo ^a   Hibiya, Takashi ^a   Takeshita, Kimiko ^a   Isogai, Maya ^a   Takada, Kenzo ^b   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CpG island methylation; Epstein Barr virus; Gastric cancer; Immunohistochemistry; SOX9

Indexed keywords

TRANSCRIPTION FACTOR SOX9; SOX9 PROTEIN, HUMAN;

ADENOMA; ADULT; AGED; ARTICLE; CANCER CELL; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CPG ISLAND; EPSTEIN BARR VIRUS; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; STOMACH CANCER; UPREGULATION; BIOSYNTHESIS; CELL TRANSFORMATION; DNA METHYLATION; EPSTEIN BARR VIRUS INFECTION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TISSUE MICROARRAY; VIROLOGY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84860322979     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1201-7     Document Type: Article

References (40)

1. Uozaki H, Fukayama M (2008) Epstein-Barr virus and gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1:198-216
2. Uozaki H, Barua RR, Sun M et al (2011) Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancer. Int J Clin Exp Pathol 4:230-240
3. Park DY, Srivastava A, Kim GH et al (2010) CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance. Mod Pathol 23:54-61
4. Haveri H, Westerholm-Ormio M, Lindfors K et al (2008) Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol 8:9
5. Lefebvre V, Dumitriu B, Penzo-Mendez A et al (2007) Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 39:2195-2214 (Pubitemid 47484275)
6. Kent J, Wheatley SC, Andrews JE et al (1996) A male-specific role for SOX9 in vertebrate sex determination. Development 122:2813-2822 (Pubitemid 26326513)
7. Lefebvre V, Huang W, Harley VR et al (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346 (Pubitemid 27133320)
8. Stolt CC, Lommes P, Sock E et al (2003) The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 17:1677-1689 (Pubitemid 36828793)
9. Perez-Alcala S, Nieto MA, Barbas JA (2004) LSox5 regulates RhoB expression in the neural tube and promotes generation of the neural crest. Development 131:4455-4465 (Pubitemid 39409687)
10. Foster JW, Dominguez-Steglich MA, Guioli S et al (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530 (Pubitemid 24368528)
11. De Santa BP, Bonneaud N, Boizet B et al (1998) Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 18:6653-6665 (Pubitemid 28500554)
12. Blache P, van de Wetering M, Duluc I et al (2004) SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 166:37-47 (Pubitemid 38931915)
13. Fukayama M, Hino R, Uozaki H (2008) Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 99:1726-1733
14. Lu B, Fang Y, Xu J et al (2008) Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 130:897-904
15. Thomsen MK, Ambroisine L,Wynn S et al (2010) SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res 70:979-987
16. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1:10-24
17. Lauren P (1965) The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 64:31-49
18. Sinicrope FA, Ruan SB, Cleary KR et al (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237-241
19. Iwasaki Y, Chong JM, Hayashi Y et al (1998) Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321-8326 (Pubitemid 28421831)
20. Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371-4378 (Pubitemid 28188743)
21. Shimizu N, Yoshiyama H, Takada K (1996) Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70:7260-7263 (Pubitemid 26307449)
22. Aleman A, Adrien L, Lopez-Serra L et al (2008) Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer 98:466-473 (Pubitemid 351161244)
23. Chang MS, Uozaki H, Chong JM et al (2006) CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res 12:2995-3002 (Pubitemid 43837343)
24. Stolt CC, Wegner M (2010) SoxE function in vertebrate nervous system development. Int J Biochem Cell Biol 42:437-440
25. Akiyama H (2008) Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18:213-219
26. Thomsen MK, Francis JC, Swain A (2008) The role of Sox9 in prostate development. Differentiation 76:728-735 (Pubitemid 352032748)
27. Barrionuevo F, Scherer G (2010) SOX E genes: SOX9 and SOX8 in mammalian testis development. Int J Biochem Cell Biol 42:433-436
28. Moniot B, Biau S, Faure S et al (2004) SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals. Development 131:3795-3804 (Pubitemid 39199386)
29. Mori-Akiyama Y, van den Born M, van Es JH et al (2007) SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 133:539-546 (Pubitemid 47187347)
30. Bastide P, Darido C, Pannequin J et al (2007) Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178:635-648 (Pubitemid 47267275)
31. Yasui W, Oue N, Sentani K et al (2009) Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol Int 59:121-136
32. Chen Y, Zhang Y-Z, Zhou Z-G et al (2006) Identification of differently expressed genes in human colorectal adenocarcinoma. World J Gastroenterol 12:1025-1032
33. Jiang SS, Fang W-T, Hou Y-H et al (2010) Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res 16:4363-4373
34. Wang H, Leav I, Ibaragi S et al (2008) SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 68:1625-1630 (Pubitemid 351416545)
35. Passeron T, Valencia JC, Namiki T et al (2009) Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest 119:954-963
36. Chakravarty G, Moroz K, Makridakis NM et al (2011) Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med (Maywood) 236:145-155
37. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469-480
38. Vidal VP, Ortonne N, Schedl A (2008) SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J Cutan Pathol 35:373-379 (Pubitemid 351363761)
39. Ramocki NM, Wilkins HR, Magness ST et al (2008) Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. Endocrinology 149:261-267
40. Choi IS, Wu TT (2005) Epigenetic alterations in gastric carcinogenesis. Cell Res 15:247-254